Immunitrack (private company)
See something wrong or missing? Let us know
Offices:Copenhagen
Business model:B2B
Immunitrack’s mission is to provide the research community with tools to select or redesign drug candidates at the early stage of R&D but also to provide reagents to monitor lead drug candidates effect on patient’s immune system.
Investors:
we tracked 1 investor
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 954k
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Immunitrack
Name | Criteria | |
---|---|---|
![]() |
Atai Life Sciences
60%
|
|
![]() |
Monocl
60%
|
|
![]() |
Sano Genetics
60%
|
|
![]() |
Causaly
60%
|
|
![]() |
Clustermarket
60%
|
|
![]() |
Bionomous
55%
|
|
![]() |
iLoF
55%
|
|
![]() |
Novai
55%
|
|
![]() |
Valink Therapeutics
55%
|
|
![]() |
Adesante
52%
|
|